Cleared Traditional

K922064 - MODEL #510 STEALTH-PLATE DISPERSIVE ELECTRODE

K922064 is an FDA 510(k) clearance for MODEL #510 STEALTH-PLATE DISPERSIVE ELE..., manufactured by Cardiotronics, Inc.. The device is a Class 2 Neurology device with product code GXD cleared through the Traditional 510(k) pathway after a 211-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1992
Decision
211d
Days
Class 2
Risk

K922064 is an FDA 510(k) clearance for the MODEL #510 STEALTH-PLATE DISPERSIVE ELECTRODE. Classified as Generator, Lesion, Radiofrequency (product code GXD), Class II - Special Controls.

Submitted by Cardiotronics, Inc. (West Carlsbad, US). The FDA issued a Cleared decision on December 1, 1992 after a review of 211 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K922064

510(k) Number K922064 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 04, 1992
Decision Date December 01, 1992
Days to Decision 211 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
62d slower than avg
Panel avg: 149d · This submission: 211d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXD Device Classification - Class 2, Special Controls

Product Code GXD Generator, Lesion, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXD Generator, Lesion, Radiofrequency

All 37
Devices cleared under the same product code (GXD) and FDA review panel - the closest regulatory comparables to K922064.
RFG-3CF
K965182 · Radionics, Inc. · Mar 1997
RADIONICS SLUIJTER-MEHTA CANNULA
K963577 · Radionics, Inc. · Nov 1996
LEKSELL NEURO GENERATOR AND ACCESSORIES
K941823 · Elekta Instruments, Inc. · Mar 1996
MODEL RFG-3C RADIOFREQUENCY LESION GENERATOR
K901540 · Radionics, Inc. · Apr 1991
NEURO N 50 LESION GENERATOR
K896450 · Leibinger & Fischer , Ltd. · Mar 1991